Newspaper Publication for Standalone Unaudited Financial Results for the quarter ended 30th June, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jenburkt Pharmaceuticals has submitted to BSE the newspaper clippings of its standalone unaudited financial results for the quarter ended 30 June 2025, as published on 13 August 2025 in The Free Press Journal (English) and Navshakti (Marathi). The Board of Directors had approved these results at their meeting held on 12 August 2025. The detailed financial numbers are not included in this notice itself — the document only confirms that the results were published and directs readers to the BSE website and the company's investor page for the full format. The filing is made in compliance with SEBI's Listing Obligations and Disclosure Requirements (Regulation 33 read with Regulation 47(1)).
This is a routine regulatory compliance filing and does not contain new financial information beyond the publication requirement itself. Shareholders looking for the actual Q1 numbers need to check the BSE website or the company's investor page. There is no direct impact on the stock price from this specific filing.